Related Experiment Video

Updated: Apr 17, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.6K

Significance of SALL4 as a drug‑resistant factor in lung cancer

Nozomi Yanagihara1, Daisuke Kobayashi1, Kageaki Kuribayashi1

  • 1Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo 060‑8543, Japan.

International Journal of Oncology
|February 4, 2015
PubMed

Insights

High SALL4 expression in lung cancer cells increases resistance to chemotherapy drugs like cisplatin and paclitaxel. This overexpression is linked to cancer recurrence after treatment, suggesting SALL4 as a resistance factor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • SALL4 is a transcription factor crucial for embryonic development and stem cell self-renewal.
  • Its role in cancer drug resistance, particularly in lung cancer, remains largely unexplored.

Purpose of the Study:

  • To investigate the significance of SALL4 as a natural resistance factor against anticancer drugs in lung cancer.
  • To evaluate the clinical significance of SALL4 expression in relation to therapeutic outcomes and recurrence in lung cancer patients.

Main Methods:

  • Small inhibitory RNA (siRNA) was used to reduce SALL4 expression in lung cancer cell lines (A549, SBC-3).
  • Sensitivity to cisplatin (CDDP), carboplatin (CBDCA), and paclitaxel (PTX) was assessed.
  • SALL4 expression levels in tumor tissues from 31 lung cancer patients were analyzed in correlation with clinical data and treatment outcomes.

Main Results:

  • Reducing SALL4 expression in lung cancer cells increased their sensitivity to CDDP, CBDCA, and PTX.
  • SALL4 expression was significantly higher in lung cancer patients who experienced recurrence compared to disease-free patients.
  • Higher SALL4 expression correlated with a shorter time to cancer recurrence after adjuvant chemotherapy.

Conclusions:

  • Overexpression of SALL4 confers natural resistance to common anticancer drugs in lung cancer.
  • SALL4 may play a significant role in the recurrence of lung cancer following adjuvant chemotherapy.
  • SALL4 represents a potential therapeutic target for overcoming drug resistance and preventing lung cancer recurrence.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.4K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
72
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
166